RGD Reference Report - Blocking the receptor for advanced glycation end product activation attenuates autoimmune myocarditis. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

Blocking the receptor for advanced glycation end product activation attenuates autoimmune myocarditis.

Authors: Yang, WI  Lee, D  Lee da, L  Hong, SY  Lee, SH  Kang, SM  Choi, DH  Jang, Y  Kim, SH  Park, S 
Citation: Yang WI, etal., Circ J. 2014;78(5):1197-205. Epub 2014 Mar 6.
RGD ID: 8696002
Pubmed: PMID:24599045   (View Abstract at PubMed)

BACKGROUND: The Receptor for Advanced Glycation End Products (RAGE) is a pattern recognition receptor for endogenous ligands, and is associated with various inflammatory diseases. However, the role of RAGE activation in myocarditis has yet to be examined. The potential role of RAGE in the development of experimental autoimmune myocarditis (EAM) and the effect of RAGE blocking in attenuating the inflammation in the EAM was investigated. METHODS AND RESULTS: EAM was evoked in Lewis rats by immunization with porcine cardiac myosin. Soluble RAGE (sRAGE) was injected to block RAGE activation. Echocardiogram, histological, and immunohistochemical examinations were conducted on days 21 and 42. In rats with EAM, RAGE expression in cardiac tissue was prominent on day 21. Rats administered sRAGE during the early antigen-priming phase showed marked attenuation in acute and chronic inflammation compared with untreated rats. RAGE expression was significantly reduced in rats treated in the early phase. However, sRAGE administration, after the initial antigen-priming phase, failed to ameliorate EAM development. CONCLUSIONS: RAGE expression was significantly increased in the heart during EAM. Blocking RAGE activation with sRAGE during the early antigen-priming phase reduced acute and chronic inflammation and improved cardiac function. In contrast, blocking RAGE after the early phase did not attenuate EAM development. These results imply that RAGE is involved in regulating innate immune responses during the early phase of myocarditis development.

RGD Manual Disease Annotations    Click to see Annotation Detail View
TermQualifierEvidenceWithReferenceNotesSourceOriginal Reference(s)
Experimental Autoimmune Myocarditis  ISOAger (Rattus norvegicus)8696002; 8696002protein:increased expression:heartRGD 
Experimental Autoimmune Myocarditis  IEP 8696002protein:increased expression:heartRGD 
Experimental Autoimmune Myocarditis  ISOHmgb1 (Rattus norvegicus)8696002; 8696002protein:increased expression:heart and serumRGD 
Experimental Autoimmune Myocarditis  IEP 8696002protein:increased expression:heart and serumRGD 

Objects Annotated

Genes (Rattus norvegicus)
Ager  (advanced glycosylation end product-specific receptor)
Hmgb1  (high mobility group box 1)

Genes (Mus musculus)
Ager  (advanced glycosylation end product-specific receptor)
Hmgb1  (high mobility group box 1)

Genes (Homo sapiens)
AGER  (advanced glycosylation end-product specific receptor)
HMGB1  (high mobility group box 1)


Additional Information